American Society of Cataract and Refractive Surgery Meeting
American Society of Cataract and Refractive Surgery Meeting
May 16, 2020
1 min watch
Save

VIDEO: KPI-121 shows promising results as first-line dry eye therapy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video from the virtual American Society of Cataract and Refractive Surgery meeting, Edward J. Holland, MD, director of cornea services at Cincinnati Eye Institute and professor of ophthalmology at the University of Cincinnati, discusses his poster on phase 2 results with KPI-121 (Kala Pharmaceuticals) as a potential new topical therapy for the treatment of dry eye.